A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/22 (2006.01) A61K 31/4965 (2006.01) A61P 25/08 (2006.01) A61P 25/24 (2006.01)
Patent
CA 2597910
The invention is directed to a dosage form and method for administering a therapeutic agent in a sustained release manner to provide an intended therapeutic effect while minimizing the side effects associated with the therapeutic agent. The therapeutic agent is selected from a group of substituted pyrazine compounds and may be (3)-(2,3,5-trichloro-phenyl)- pyrazine-(2,6)-diamine.
Forme posologique et procédé d'administration d'un agent thérapeutique dans une libération soutenue afin de produire un effet thérapeutique souhaité tout en minimisant les effets secondaires associés à l'agent thérapeutique. L'agent thérapeutique est sélectionné dans un groupe de composés pyrazine substitués et peut être (3)-(2,3,5-trichloro-phényl)-pyrazine-(2,6)-diamine.
Des Jardin Michael
Foreman Mark
Pfeiffer James
Saks Samuel
Wissel Janne
Jazz Pharmaceuticals Inc.
Smart & Biggar
LandOfFree
Dosage form and method for sustained release of a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dosage form and method for sustained release of a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dosage form and method for sustained release of a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1954077